Clindamycin Injection (Iv/Im) 300 mg/2 mL, 600 mg/4 mL Suppliers & Bulk Manufacturers
Available Forms: Injection (IV/IM)
Available Strengths: 300 mg/2 mL, 600 mg/4 mL
Reference Brands: Cleocin, Clindamycin, Dalacin C(US); Dalacin C, Clindamycine(EU)
Category: Antibiotics
Clindamycin IV and IM inhibit bacterial protein synthesis by binding to the 50S ribosomal subunit, leading to bacterial cell death. It effectively treats severe skin, respiratory, and intra-abdominal infections. Benefits include rapid, reliable action against anaerobic bacteria, good tissue penetration, and clinical utility in hospital settings.
Product Description:
Clindamycin IV/IM is approved in the EU and US for severe bacterial infections, including skin, respiratory, and intra-abdominal infections. In the EU, brands like Cleocin are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing quality. In the US, FDA approval relies on extensive clinical data; generic formulations are widely available. Both regions require detailed dossiers, including clinical trial results, manufacturing standards, and pharmacovigilance plans for approval and ongoing safety monitoring. For expert regulatory support, dossier preparation, and compliance, visit PharmaTradz. We facilitate seamless market access for clindamycin IV/IM, ensuring adherence to European and US standards for safe, effective antimicrobial therapy.
Clindamycin Injection (Iv/Im) — third party manufacturing & bulk supply
Clindamycin Injection (Iv/Im) 300 mg/2 mL, 600 mg/4 mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Clindamycin Injection (Iv/Im) listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Clindamycin Injection (Iv/Im) →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Clindamycin Injection is used to treat serious bacterial infections caused by susceptible bacteria, particularly anaerobic bacteria and certain gram-positive organisms. It is commonly prescribed for respiratory tract infections, skin and soft tissue infections, bone and joint infections, intra-abdominal infections, septicemia, and gynecological infections. The injectable form is typically used in hospital settings when oral therapy is not suitable or when rapid therapeutic action is required.
Clindamycin Injection contains the active pharmaceutical ingredient clindamycin phosphate, which is the injectable form of the antibiotic clindamycin. It belongs to the lincosamide class of antibiotics and works by inhibiting bacterial protein synthesis, thereby preventing the growth and multiplication of bacteria.
Clindamycin Injection is marketed under several trade names worldwide including Cleocin Injection, Dalacin C Injection, and other generic clindamycin injectable brands depending on the manufacturer and region.
One of the well-known brands, Cleocin Injection, was originally developed and marketed by Pfizer. Today, clindamycin injection is manufactured globally by several pharmaceutical companies including Teva Pharmaceutical Industries, Sandoz, and Viatris along with other generic manufacturers.
The generic name of Clindamycin Injection is clindamycin phosphate.
Common brand names of Clindamycin Injection include Cleocin Injection and Dalacin C Injection.
Clindamycin Injection is manufactured in several countries including the United States, India, China, and multiple European countries by different pharmaceutical manufacturers supplying both branded and generic injectable formulations for global markets.
Related Products
Rifaximin
Strength:
100 mg/5 mL, 200 mg, 550 mg
Form: Tablet / Oral Suspension
Reference Brands: Xifaxan (USA), Targaxan (EU), Normix (LATAM)
View Details
Ceftaroline
Strength:
600 mg
Form: Injection
Reference Brands: Teflaro (USA), Zinforo (EU)
View Details
Quick Response Guaranteed | Verified Suppliers
